Rare Disease CME/CE Online Courses

myCME Your search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.

Featured Courses

The New Frontier of Personalized gMG Management: Integrating FcRn Inhibitors Across the Continuum of Care With Point-Counterpoint Case Presentations

The New Frontier of Personalized gMG Management | myCME

AMA PRA Category 1 Credit(s)^TM, CE for Pharmacists

1.00 CME CPE: Myasthenia Gravis: Management With FcRn Inhibitors. The integration of these novel compounds via challenging case studies. Exp 11/22/23

Understanding Lysosomal Storage Disorders: From Newborn Screening to Treatments

Understanding Lysosomal Storage Disorders | myCME

AMA PRA Category 1 Credit(s)^TM

1.00 CME CE: General characteristics and clinical markers to aid recognition of Lysosomal Storage Disorders and key studies regarding therapy. Exp 12/6/23

Breakthroughs in Paroxysmal Nocturnal Hemoglobinuria Treatment: Targeting Alternative Pathways of Complement Inhibition

Complement Inhibition in Paroxysmal Nocturnal Hemoglobinuria | myCME

AMA PRA Category 1 Credit(s)^TM, CE for Pharmacists

1.00 CME CE: A lively expert discussion and real-world clinical case on PNH. Exp 6/30/23

Gene Therapy for X-Linked Retinitis Pigmentosa: Implications for Clinical Practice Right Now

Gene Therapy for XLRP: Implications for Clinical Practice | myCME

AMA PRA Category 1 Credit(s)^TM, COPE CE Credit(s)

1.00 CME COPE: XLRP: Diagnosis, genetic testing, clinical trials, and support. Exp 6/30/23

$Mitigating Veno-occlusive Disease Risk in Patients Treated for Relapsed/Refractory B-cell Precursor ALL$

Mitigating Veno-occlusive Disease Risk in R/R ALL | myCME

AMA PRA Category 1 Credit(s)^TM

0.50 CME: Veno-occlusive disease is a life-threatening condition. Early recognition and management are paramount to recovery. This activity is designed for the interdisciplinary care team. Exp 12/2/23

Rett Syndrome: Hope for Patients and Caregivers | myCME

AMA PRA Category 1 Credit(s)^TM

1.00 CME: Panelists will review the stages of Rett syndrome, diagnosis criteria, disease-causing genetic mutations, and genetic testing. Exp 3/29/23

Recent Advances and Emerging Trends in the Diagnosis and Management of Giant Cell Arteritis

Advances in Diagnosis and Management of Giant Cell Arteritis | myCME

AMA PRA Category 1 Credit(s)^TM

1.00 CME: Discussion highlighted by whiteboard elements and summarized by a whiteboard animation illustrating current practice in GCA management. Exp 9/15/23

Immunoglobulin Replacement Therapies for PIDD: Clinical Trials and Real-world Evidence to Enhance Diagnosis and Individualize Treatment

Immunoglobulin Replacement Therapies for PIDD | myCME

AMA PRA Category 1 Credit(s)^TM

1.00 CME: PIDD patient presentations, disease and treatment burdens, and dosing and administration specifications for IVIG and SCIG therapies. Exp 8/12/23

Improving Diagnosis and Clinical Monitoring of Acid Sphingomyelinase Deficiency

Improving Diagnosis and Clinical Monitoring of ASMD | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s)

1.00 CME CE: Experts Drs. Margaret McGovern and Pramod Mistry review the diagnosis and treatment of acid sphingomyelinase deficiency. Exp 5/27/23

Prurigo Nodularis - Novel Approaches to Chronic Pruritus

Updates in Treatment of Prurigo Nodularis | myCME

AMA PRA Category 1 Credit(s)^TM, AANP Contact Hour(s)

1.00 CME CE: This activity addresses the challenges of prurigo nodularis and evolving therapies to manage chronic pruritus using immune-based approaches. Exp 6/30/23

Improving HoFH Outcomes: Strategies for Better Treatment and Reduced Barriers to Care

Improving Homozygous Familial Hypercholesterolemia Outcomes | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s)

CME 1.00: Discusses diagnosing and treating HoFH patients and how to improve HoFH patient outcomes and quality of life. Exp 4/14/23

The Dawning of a New Era in the Management of Prurigo Nodularis: A Focus on the Patient Experience, Differential Diagnoses, and Emerging Treatment Options

A New Era in the Management of Prurigo Nodularis | myCME

AMA PRA Category 1 Credit(s)^TM

0.75 CME: This course educates dermatologists and other clinicians on the pathogenesis and diagnosis of Prurigo Nodularis. Exp 7/29/23